Patent · US Active

Protein stabilization formulations

US8435943B2 · kind B2 · utility

5Cited by
66References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2011
Grant dateMay 7, 2013
Priority date
Expiry dateMay 2, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to stabilizing Bone Morphogenetic Protein in various lyophilized formulations and compositions. The present invention comprises formulations primarily including trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.